Electrophysiologic considerations in congenital heart disease and their relationship to heart failure

Carolina Escudero1, Paul Khairy, Shubhayan Sanatani

  • 1Division of Pediatric Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Insights

Adult congenital heart disease (CHD) survivors face increased risks of heart failure and arrhythmias due to complex physiology and interventions. Understanding this interplay is crucial for managing these complex cardiac conditions.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease
  • Cardiac Electrophysiology

Background:

  • Adult survivors of complex congenital heart disease (CHD) have unique physiological challenges.
  • Previous interventions and inherent structural abnormalities predispose CHD patients to heart failure and arrhythmias.
  • The relationship between arrhythmias and heart failure in CHD is intricate and bidirectional.

Purpose of the Study:

  • To explore the complex interplay between arrhythmogenesis, congenital heart disease (CHD), and heart failure.
  • To review risk factors and arrhythmia substrates in adult CHD survivors.
  • To highlight the importance of specialized care for complex CHD patients.

Main Methods:

  • Review of current literature on arrhythmias and heart failure in congenital heart disease.
  • Analysis of the impact of surgical interventions on cardiac electrophysiology.
  • Discussion of diagnostic and therapeutic strategies for managing arrhythmias in CHD.

Main Results:

  • Both native CHD and surgical repairs can lead to conduction system abnormalities and arrhythmias.
  • Arrhythmias are significant risk factors for sudden cardiac death in the CHD population.
  • Device therapies are increasingly utilized for managing chronotropic incompetence, cardiac resynchronization, and preventing sudden death.

Conclusions:

  • Management of adult CHD requires a comprehensive understanding of the relationship between arrhythmias and heart failure.
  • Specialized centers are recommended for the care of complex CHD patients.
  • Continued research into arrhythmogenesis in CHD is essential for improving long-term outcomes.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...